In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species

Journal of Infection and Chemotherapy

Volumn 15, Issue 1, 2009, Pages 1-5

  Nishi, Isao ^a,b   Sunada, Atsuko ^a   Toyokawa, Masahiro ^a   Asari, Seishi ^a   Iwatani, Yoshinori ^b  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amphotericin B; Candida; Combination effect; Fluconazole; Micafungin; Voriconazole

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; MICAFUNGIN; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FUNGUS; IN VITRO STUDY; NONHUMAN;

EID: 62449205550     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0653-9     Document Type: Article

References (15)

1. A. Cornillet C. Camus S. Nimubona V. Gandemer P. Tattevin C. Belleguic 2006 Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey Clin Infect Dis 43 577 584
2. J.M. Rabkin S.L. Oroloff C.L. Corless K.G. Benner K.D. Flora H.R. Rosen 2000 Association of fungal infection and increased mortality in liver transplant recipients Am J Surg 179 426 430
3. J. Capilla E. Mayayo C. Serena F.J. Pastor J. Guarro 2004 A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B J Antimicrob Chemother 54 1092 1095
4. L.B. Johnson C.A. Kauffman 2003 Voriconazole: a new triazole antifungal agent Clin Infect Dis 36 630 637
5. D.W. Denning G.G. Baily S.V. Hood 1997 Azole resistance in Candida Eur J Clin Microbiol Infect Dis 16 261 280
6. M.D. Johnson C. MacDougall L. Ostrosky-Zeichner J.R. Perfect J.H. Rex 2004 Combination antifungal therapy Antimicrob Agents Chemother 48 693 715
7. F. Ikeda Y. Wakai S. Matsumoto K. Maki E. Watabe S. Tawara 2000 Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis Antimicrob Agents Chemother 44 614 618
8. E.R. Kuse P. Chetchotisakd C.A. Cunha M. Ruhnke C. Barrios D. Raghunadharao 2007 Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomized double-blind trial Lancet 369 1519 1527
9. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, second edition. NCCLS document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
10. D.J. Krogstad R.C. Moellering 1986
11. K. Heyn A. Tredup S. Salvenmoser F.M. Muller 2005 Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosproium spp. and Fusarium solani Antimicrob Agents Chemother 49 5157 5159
12. Y. Nishiyma K. Uchida H. Yamaguchi 2002 Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopetide J Electron Microsc 51 247 255
13. Y. Nishiyma H. Yamaguchi 2005 Morphological studies of micafungin action against Candida glabrata (in Japanese) Jpn J Bacteriol 60 175
14. J.A. Olson J.P. Adler-Moore P.J. Smith R.T. Proffitt 2005 Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin Antimicrob Agents Chemother 49 4895 4902
15. A.S. Ibrahim T. Gebremariam Y. Fu J.E. Edwards Jr B. Spellberg 2008 Combination echinocandin-polyene treatment of murine mucormycosis Antimicrob Agents Chemother 52 1556 1558